Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease.
Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease.
Copyright © 2024 | WordPress Theme by MH Themes
